)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Lipella Pharmaceuticals
Lipella Pharmaceuticals (LIPO) investor relations material
Lipella Pharmaceuticals Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary14 Nov, 2025
Executive summary
Focused on developing reformulated generic drugs for new indications, with lead programs LP-10 (hemorrhagic cystitis) and LP-310 (oral lichen planus) in clinical development; LP-410 (oral GVHD) and LP-50 (bladder cancer) in earlier stages.
No commercialized products; revenue derived from NIH grants, which expired in June 2025.
Announced completion of LP-310 Phase 2a trial in Q3 2025, with positive safety and tolerability data.
Chief Medical Officer announced retirement effective December 2025.
Financial highlights
Revenue for Q3 2025 was $0, down from $80,380 in Q3 2024 due to grant expiration.
Net loss for Q3 2025 was $1.25M, improved from $1.44M in Q3 2024; net loss for nine months ended September 30, 2025 was $3.89M, up from $3.57M in 2024.
R&D expenses for Q3 2025 were $721K, down $326K year-over-year, mainly due to lower stock option expense.
General and administrative expenses for Q3 2025 were $552K, up $60K year-over-year, driven by higher professional and outside services.
Cash and cash equivalents at September 30, 2025 were $1.86M.
Outlook and guidance
Existing cash expected to fund operations through the end of 2025, but additional capital will be required for continued development.
Anticipates continued operating losses and negative cash flows due to ongoing R&D and clinical activities.
What is the impact of OTC trading on capital?
Detail plans to address going concern beyond 2025
How will LP-310 Phase 2a results guide R&D spend?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Lipella Pharmaceuticals
- Biotech registers 1.37M shares for resale, targeting rare diseases and facing Nasdaq risks.LIPO
Registration Filing16 Dec 2025 - Biotech registers 5.6M shares for resale, supporting pipeline and working capital amid Nasdaq risks.LIPORegistration Filing16 Dec 2025
- Annual meeting to vote on director elections, reverse stock split, and auditor ratification.LIPOProxy Filing2 Dec 2025
- Shareholders will vote on issuing 20%+ of stock via an equity line to regain Nasdaq compliance.LIPOProxy Filing2 Dec 2025
- Annual meeting to vote on directors, stock plan amendment, share issuances, and auditor ratification.LIPOProxy Filing2 Dec 2025
- Shareholders will vote on director elections, a reverse stock split, and auditor ratification.LIPOProxy Filing2 Dec 2025
- Shareholders to vote on issuing 20%+ new shares via ELOC to regain Nasdaq compliance and fund growth.LIPOProxy Filing2 Dec 2025
- Special stockholder meeting adjourned for lack of quorum, rescheduled for December 27, 2024.LIPOProxy Filing2 Dec 2025
- Special stockholder meeting adjourned for lack of quorum, rescheduled for December 20, 2024.LIPOProxy Filing2 Dec 2025
Next Lipella Pharmaceuticals earnings date
Q4 20253 Apr, 2026
Lipella Pharmaceuticals
Next Lipella Pharmaceuticals earnings date
Q4 20253 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage